Healthcare disparities in cardio oncology: patients receive same level of surveillance regardless of race at a safety net hospital

Healthcare disparities in cardio oncology: patients receive same level of surveillance regardless of race at a safety net hospital

Abstract Background Cardiotoxicity remains a dreaded complication for patients undergoing chemotherapy with human epidermal growth factor (HER)-2 receptor antagonists and anthracyclines. Though many studies have looked at racial disparities in heart failure patients, minimal data is present for the...

Full description

Bibliographic Details
Main Authors: Crystal B. Chen, Raj K. Dalsania, Eman A. Hamad
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Cardio-Oncology
Subjects:
Cardio-oncology
Heart failure
Chemotherapy
Cardiotoxicity
Disparity
Income
Online Access:https://doi.org/10.1186/s40959-020-00080-w

Internet

https://doi.org/10.1186/s40959-020-00080-w

Similar Items